Grants and Funding
NIH Human Embryonic Stem Cell Registry
Submitted hESC Lines Pending Review

The following is a list of human embryonic stem cell lines submitted to NIH, which are PENDING review to determine if they may be used in NIH funded research.

Pending Lines: 
Sorted by:
Date/Time:
81  (in 16 Submissions)
Organization Name (descending), Cell Line Name
09/22/2014 at 07:59 PM
Cell Line Name Organization Descending Sort Date Submitted
UM112-1 PGD; disease-specific mutation University of Michigan 06/04/2014
UM114-10 University of Michigan 06/25/2014
UM121-7 University of Michigan 06/25/2014
UM134-1 PGD; disease-specific mutation University of Michigan 06/04/2014
UM139-2 PGD; disease-specific mutation University of Michigan 06/25/2014
UM76-1 PGS; abnormal karyotype University of Michigan 06/25/2014
UM78-2 University of Michigan 06/04/2014
UM90-12 PGS; abnormal karyotype University of Michigan 06/04/2014
UCLA 13 University of California, Los Angeles 06/18/2014
UCLA 14 University of California, Los Angeles 06/18/2014
UCLA 15 University of California, Los Angeles 06/18/2014
UCLA 16 University of California, Los Angeles 06/18/2014
UCLA 17 University of California, Los Angeles 06/18/2014
UCLA 18 University of California, Los Angeles 06/18/2014
UCSFB1 University of California San Francisco * 12/04/2009
UCSFB10 University of California San Francisco * 12/04/2009
UCSFB2 University of California San Francisco * 12/04/2009
UCSFB3 University of California San Francisco * 12/04/2009
UCSFB4 University of California San Francisco * 12/04/2009
UCSFB5 University of California San Francisco * 12/04/2009
UCSFB6 University of California San Francisco * 12/04/2009
UCSFB7 University of California San Francisco * 12/04/2009
UCSFB8 University of California San Francisco * 12/04/2009
UCSFB9 University of California San Francisco * 12/04/2009
Lis 40_t(13;14)_N Tel Aviv Sourasky Medical Center 09/16/2014
Lis 44_t(13;14)_2_N Tel Aviv Sourasky Medical Center 09/16/2014
Lis 49_Hydrocephaly_2_N Tel Aviv Sourasky Medical Center 09/16/2014
Lis_19_DM_2 (Myotonic Dystrophy) Tel Aviv Sourasky Medical Center 09/16/2014
Lis01_HEFX1 (Fragile X) Tel Aviv Sourasky Medical Center 09/16/2014
Lis02_FXS_2 (Fragile X) Tel Aviv Sourasky Medical Center 09/16/2014
Lis03_FXS_4 (Fragile X) Tel Aviv Sourasky Medical Center 09/16/2014
Lis04_Twist (Saethre-Chotzen Syndrome) Tel Aviv Sourasky Medical Center 09/16/2014
Lis05_t(11,22) Tel Aviv Sourasky Medical Center 09/16/2014
Lis06_Gaucher_1 Tel Aviv Sourasky Medical Center 09/16/2014
Lis07_AIS_1 (Androgen Insensitivity) Tel Aviv Sourasky Medical Center 09/16/2014
Lis08_AIS_2 (Androgen Insensitivity) Tel Aviv Sourasky Medical Center 09/16/2014
Lis09_DYS_1 Tel Aviv Sourasky Medical Center 09/16/2014
Lis10_DMD_1 (Duchenne Muscular Dystrophy) Tel Aviv Sourasky Medical Center 09/16/2014
Lis11_DMD_2 (Duchenne Muscular Dystrophy) Tel Aviv Sourasky Medical Center 09/16/2014
Lis12_DM_1 (Myotonic Dystrophy) Tel Aviv Sourasky Medical Center 09/16/2014
Lis13_ Alport_2 Tel Aviv Sourasky Medical Center 09/16/2014
Lis14_ Alport_3 Tel Aviv Sourasky Medical Center 09/16/2014
Lis15_t(1;12) Tel Aviv Sourasky Medical Center 09/16/2014
Lis17_Connexin_1 (Non Syndromic Deafness) Tel Aviv Sourasky Medical Center 09/16/2014
Lis18_Connexin_2 (Non Syndromic Deafness) Tel Aviv Sourasky Medical Center 09/16/2014
Lis20_DMD_3 (Duchenne Muscular Dystrophy) Tel Aviv Sourasky Medical Center 09/16/2014
Lis21_Noonan Tel Aviv Sourasky Medical Center 09/16/2014
Lis22_DMD_4 (Duchenne Muscular Dystrophy) Tel Aviv Sourasky Medical Center 09/16/2014
Lis23_DMD_5 (Duchenne Muscular Dystrophy) Tel Aviv Sourasky Medical Center 09/16/2014
Lis24_FXS_5 (Fragile x) Tel Aviv Sourasky Medical Center 09/16/2014
Lis25_FAP_1 (Familial Adenomatous Polyposis) Tel Aviv Sourasky Medical Center 09/16/2014
Lis26_FXS_6 (Fragile X) Tel Aviv Sourasky Medical Center 09/16/2014
Lis27_t(Y;14)_1 Tel Aviv Sourasky Medical Center 09/16/2014
Lis28_t(Y;14)_2 Tel Aviv Sourasky Medical Center 09/16/2014
Lis29_FXS_7 (Fragile X) Tel Aviv Sourasky Medical Center 09/16/2014
Lis30_FAP_2 (Familial Adenomatous Polyposis) Tel Aviv Sourasky Medical Center 09/16/2014
Lis31_DM_3 (Myotonic Dystrophy) Tel Aviv Sourasky Medical Center 09/16/2014
Lis32_DM_4 (Myotonic Dystrophy) Tel Aviv Sourasky Medical Center 09/16/2014
Lis33_Norrie Tel Aviv Sourasky Medical Center 09/16/2014
Lis34_FAP_3 (Familial Adenomatous Polyposis) Tel Aviv Sourasky Medical Center 09/16/2014
Lis35_Hydrocephaly Tel Aviv Sourasky Medical Center 09/16/2014
Lis36_t(11;20)_N Tel Aviv Sourasky Medical Center 09/16/2014
Lis37_FXS_10 (Fragile X) Tel Aviv Sourasky Medical Center 09/16/2014
Lis38_FXS_7_N (Fragile X) Tel Aviv Sourasky Medical Center 09/16/2014
Lis39_FXS_8_N (Fragile X) Tel Aviv Sourasky Medical Center 09/16/2014
Lis41_LTBL_N (Leukoencephalopathy Thalamus Brainstem involvement and high Lactate) Tel Aviv Sourasky Medical Center 09/16/2014
Lis42_NF1_1_N (Neurofibromatosis type I) Tel Aviv Sourasky Medical Center 09/16/2014
Lis43_Connexin_3_N (Non Syndromic Deafness) Tel Aviv Sourasky Medical Center 09/16/2014
Lis45_Ichthyosis_1_N Tel Aviv Sourasky Medical Center 09/16/2014
Lis46_Ichthyosis_2_N Tel Aviv Sourasky Medical Center 09/16/2014
Lis47_NF1_2_N (Neurofibromatosis type I) Tel Aviv Sourasky Medical Center 09/16/2014
Lis48_DMD_6_N (Duchenne Muscular Dystrophy) Tel Aviv Sourasky Medical Center 09/16/2014
Lis50_Hydrocephaly_3_N Tel Aviv Sourasky Medical Center 09/16/2014
Lis51__FXS_9_N (Fragile X) Tel Aviv Sourasky Medical Center 09/16/2014
MA 09 Advanced Cell Technology, Inc. * 12/30/2009
MA 42 Advanced Cell Technology, Inc. 02/04/2010
MA 50 Advanced Cell Technology, Inc. 02/04/2010
NED 1 Advanced Cell Technology, Inc. * 12/24/2009
NED 2 Advanced Cell Technology, Inc. * 12/24/2009
NED 3 Advanced Cell Technology, Inc. * 12/24/2009
NED 4 Advanced Cell Technology, Inc. * 12/24/2009

* This cell line is ineligible for review under the NIH Guidelines for Human Stem Cell Research because the line was derived from a pre-blastocyst embryo. The Guidelines define human embryonic stem cells as "cells that are derived from the inner cell mass of blastocyst stage human embryos..." NIH has proposed a change to this definition, and therefore has not deleted this submission from the "Pending Review" list.


Total Pending Lines = 81


Go to NIH Form 2890 Login Page

Go to NIH Stem Cell Information Page


   
Related Resources

    NIH Form 2890:

  • Login Page
    (Authorization Required)
    Contact Us:

  • Email questions to:
    hescregistry@mail.nih.gov

  • (Emails that are offensive or unrelated to stem cells will be deleted.)
 

This page last updated on July 13, 2011
Content Manager: stemcell@mail.nih.gov 
Technical Issues: E-mail OER Webmaster